Chemours (CC) PT Lowered to $9 at UBS
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $15.33 -2.48%
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Join SI Premium – FREE
UBS analyst John Roberts lowered the price target on Chemours (NYSE: CC) to $9.00 (from $10.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Rockwell Medical Technologies (RMTI) PT Lowered to $20 at Maxim Group
- Nebius Group (NBIS) PT Raised to $250 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
